Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma-Reference-Cited by-同舟云学术

Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma

Published:2013-06 Issue:6 Volume:37 Page:874-881
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Gilks C. Blake,Oliva Esther,Soslow Robert A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference27 articles.

1. Contemporary management of endometrial cancer.;Wright;Lancet,2012

2. Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study.;Halperin;Eur J Gynaecol Oncol,2002

3. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.;Creasman;Gynecol Oncol,2004

4. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers.;Hamilton;Br J Cancer,2006

5. Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: multicentre randomized trial.;Creutzberg;Lancet,2000

Cited by 302 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics;International Journal of Gynecological Pathology;2024-02-02

2. Metastases and Recurrence Risk Factors in Endometrial Cancer—The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures;Cancers;2023-12-29

3. Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas;Pathology and Oncology Research;2023-12-11

4. Comparison of Minimally Invasive Surgery with Open Surgery for Type II Endometrial Cancer: An Analysis of the National Cancer Database;Healthcare;2023-12-08

5. Letter to the editor—The new FIGO staging system for endometrial cancer: Is the paradigm shift clinically feasible?;International Journal of Gynecology & Obstetrics;2023-12-06